Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Intima Bioscience, Inc.
Varian, a Siemens Healthineers Company
Therakos LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Institut Bergonié
Institut Bergonié
Sutro Biopharma, Inc.
Lady Davis Institute
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Allist Pharmaceuticals, Inc.
Prisma Health-Midlands
ImmunityBio, Inc.
ImmunityBio, Inc.
Auris Health, Inc.
Astellas Pharma Inc
Shanghai Pulmonary Hospital, Shanghai, China
University of Texas Southwestern Medical Center
University of Kansas Medical Center
Sun Yat-sen University
Sun Yat-sen University
ETOP IBCSG Partners Foundation
M.D. Anderson Cancer Center
ETOP IBCSG Partners Foundation
Roswell Park Cancer Institute
Indiana University
Maastricht Radiation Oncology
VA Office of Research and Development
University of British Columbia
University of Chicago
Sichuan Baili Pharmaceutical Co., Ltd.
SWOG Cancer Research Network
The Cleveland Clinic
University of Pittsburgh
Washington University School of Medicine
Institut Bergonié
Maastricht University Medical Center
National Cancer Institute (NCI)
Hetian District People's Hospital
Beijing Kejing Biotechnology Co., Ltd.
TJ Biopharma Co., Ltd.
NYU Langone Health
Kartos Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Xinqiao Hospital of Chongqing
Erasmus Medical Center
National Institutes of Health Clinical Center (CC)